Editas Medicine (EDIT) Liabilities and Shareholders Equity (2015 - 2025)
Editas Medicine (EDIT) posted Liabilities and Shareholders Equity of $186.53 million for Q4 2025, down 45.4% from $341.59 million a year earlier and down 7.5% from the prior quarter.
Powered by 
Analysis
Editas Medicine (EDIT) Liabilities and Shareholders Equity (2015 - 2025) Analysis & Trends
Since Q4 2015, Editas Medicine has reported Liabilities and Shareholders Equity for 41 quarters.
- Annual Liabilities and Shareholders Equity has declined for four consecutive years, with a five-year compound annual growth rate of -20.1% (FY2020 to FY2025).
- In prior years, Editas Medicine's Liabilities and Shareholders Equity was $341.59 million in FY2024 (-31.6%), $499.15 million in FY2023 (-2.9%), $514.32 million in FY2022 (-24.1%) and $677.48 million in FY2021 (+18.3%).
- The Q4 2025 figure stands as the lowest quarterly Liabilities and Shareholders Equity since Q4 2015.
- On a year-over-year basis, Liabilities and Shareholders Equity has declined in each of the last 16 quarters, with an average decline of 33.7% over the last eight quarters.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q1 2021, with growth of 67.2%; the weakest was Q4 2025, with a decline of 45.4%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $201.75 million (Q3 2025), $210.58 million (Q2 2025) and $263.65 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Editas Medicine | 241.55 Mn | -470.20 Mn | - | 186.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 186.53 Mn |
| Sep 30, 2025 | 201.75 Mn |
| Jun 30, 2025 | 210.58 Mn |
| Mar 31, 2025 | 263.65 Mn |
| Dec 31, 2024 | 341.59 Mn |
| Sep 30, 2024 | 327.57 Mn |
| Jun 30, 2024 | 384.80 Mn |
| Mar 31, 2024 | 440.35 Mn |
| Dec 31, 2023 | 499.15 Mn |
| Sep 30, 2023 | 504.65 Mn |
| Jun 30, 2023 | 541.95 Mn |
| Mar 31, 2023 | 464.11 Mn |
| Dec 31, 2022 | 514.32 Mn |
| Sep 30, 2022 | 531.03 Mn |
| Jun 30, 2022 | 580.83 Mn |
| Mar 31, 2022 | 623.11 Mn |
| Dec 31, 2021 | 677.48 Mn |
| Sep 30, 2021 | 717.02 Mn |
| Jun 30, 2021 | 755.88 Mn |
| Mar 31, 2021 | 780.29 Mn |
API Access
Editas Medicine Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();